Specifically, senescent endothelial cells are now known to contribute to the exacerbation of PAH by dysregulating VEGF pathways due to increased levels of soluble VEGFR1; this negatively modulates its signaling activity by trapping VEGF and preventing it from communicating with its functional receptors. The gene discussed is FLT1; the disease is pulmonary arterial hypertension.